Gastric Cancer
Copyright ©The Author(s) 2005.
World J Gastroenterol. Jul 7, 2005; 11(25): 3846-3849
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3846
Table 2 Relationship between expressions of the FADD, TRADD, FasL, Fas, NFκB proteins and clinical characteristics, n (%)
Clinical characteristicsnFADDTRADDFasLFasNFκB
Male3512 (34.3)26 (74.3)25 (71.4)21 (60.0)28 (80.0)
Female208 (40.0)12 (60.0)13 (65.0)12 (60.0)15 (75.0)
Age/yr ≤ 45228 (36.4)14 (63.6)16 (72.7)13 (59.1)16 (72.7)
> 453313 (39.4)24 (72.7)22 (66.7)20 (60.6)27 (81.8)
Tumor
Size ≤ 5 cm178 (47.1)11 (64.7)14 (82.4)15 (88.2)a14 (82.4)
> 5 cm3813 (34.2)27 (71.1)24 (63.2)17 (44.7)29 (76.3)
Grading I–II1411 (78.6)b6 (42.9)11 (78.6)14 (100.0)c11 (78.6)
III–IV419 (22.0)32 (78.1)27 (65.9)19 (46.3)32 (78.1)
CEA ≤ 30 (µg/L)85 (62.5)0 (0.0)5 (62.5)0 (0.0)5 (62.5)
> 30 (µg/L)4716 (34.0)38 (80.9)d33 (70.2)33 (70.2)d38 (80.9)
Tumor
transformation Yes63 (50.0)3 (50.0)5 (83.3)3 (50.0)3 (50.0)
No4917 (34.2)35 (71.4)33 (67.4)30 (61.2)39 (79.6)